111 related articles for article (PubMed ID: 3708589)
1. Inhibition of tumor cell collagenolytic activity by bovine endothelial cells.
DeClerck YA; Laug WE
Cancer Res; 1986 Jul; 46(7):3580-6. PubMed ID: 3708589
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor.
DeClerck YA; Yean TD; Chan D; Shimada H; Langley KE
Cancer Res; 1991 Apr; 51(8):2151-7. PubMed ID: 2009533
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R
Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232
[TBL] [Abstract][Full Text] [Related]
4. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
[TBL] [Abstract][Full Text] [Related]
5. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.
Rak JW; Hegmann EJ; Lu C; Kerbel RS
J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080.
Tanaka K; Iwamoto Y; Ito Y; Ishibashi T; Nakabeppu Y; Sekiguchi M; Sugioka Y
Cancer Res; 1995 Jul; 55(13):2927-35. PubMed ID: 7796421
[TBL] [Abstract][Full Text] [Related]
7. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
Moll UM; Youngleib GL; Rosinski KB; Quigley JP
Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by bovine endothelial cells of degradation by HT-1080 fibrosarcoma cells of extracellular matrix proteins.
Heisel M; Laug WE; Jones PA
J Natl Cancer Inst; 1983 Dec; 71(6):1183-7. PubMed ID: 6418940
[TBL] [Abstract][Full Text] [Related]
9. Invasion of an artificial blood vessel wall by human fibrosarcoma cells.
Jones PA; Neustein HB; Gonzales F; Bogenmann E
Cancer Res; 1981 Nov; 41(11 Pt 1):4613-20. PubMed ID: 7306979
[TBL] [Abstract][Full Text] [Related]
10. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.
Apodaca G; Rutka JT; Bouhana K; Berens ME; Giblin JR; Rosenblum ML; McKerrow JH; Banda MJ
Cancer Res; 1990 Apr; 50(8):2322-9. PubMed ID: 2156617
[TBL] [Abstract][Full Text] [Related]
11. Selective up-regulation of human alveolar macrophage collagenase production by lipopolysaccharide and comparison to collagenase production by fibroblasts.
Cury JD; Campbell EJ; Lazarus CJ; Albin RJ; Welgus HG
J Immunol; 1988 Dec; 141(12):4306-12. PubMed ID: 2848893
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
Laug WE
Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
[TBL] [Abstract][Full Text] [Related]
13. Interstitial collagenase is required for angiogenesis in vitro.
Fisher C; Gilbertson-Beadling S; Powers EA; Petzold G; Poorman R; Mitchell MA
Dev Biol; 1994 Apr; 162(2):499-510. PubMed ID: 7512058
[TBL] [Abstract][Full Text] [Related]
14. Type VIII collagen. Synthesis by normal and malignant cells in culture.
Sage H; Balian G; Vogel AM; Bornstein P
Lab Invest; 1984 Feb; 50(2):219-31. PubMed ID: 6694361
[TBL] [Abstract][Full Text] [Related]
15. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL
J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982
[TBL] [Abstract][Full Text] [Related]
16. Blocking of collagenase secretion by estramustine during in vitro tumor cell invasion.
Wang M; Stearns ME
Cancer Res; 1988 Nov; 48(22):6262-71. PubMed ID: 2846150
[TBL] [Abstract][Full Text] [Related]
17. Macrophage and lymphocyte potentiation of syngeneic tumor cell and host fibroblast collagenolytic activity in rats.
Dabbous MK; North SM; Haney L; Nicolson GL
Cancer Res; 1988 Dec; 48(23):6832-6. PubMed ID: 2846162
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.
Cresson DH; Beckman WC; Tidwell RR; Geratz JD; Siegal GP
Am J Pathol; 1986 Apr; 123(1):46-56. PubMed ID: 3008561
[TBL] [Abstract][Full Text] [Related]
19. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.
Dodge AB; Lu X; D'Amore PA
J Cell Biochem; 1993 Sep; 53(1):21-31. PubMed ID: 8227180
[TBL] [Abstract][Full Text] [Related]
20. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells.
Winwood PJ; Schuppan D; Iredale JP; Kawser CA; Docherty AJ; Arthur MJ
Hepatology; 1995 Jul; 22(1):304-15. PubMed ID: 7601425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
